spiperone has been researched along with 4-butyrolactone in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ekman, A; Eriksson, E | 1 |
de Vries, JB; Dijkstra, D; Grol, CJ; Horn, AS; Mulder, TB; Wiechers, JW | 1 |
Nakagawa, K; Sekihara, S; Somei, M; Watanabe, H; Yamada, F | 1 |
Bannon, MJ; Bunney, BS; Grace, AA; Roth, RH | 1 |
Haubrich, DR; Martin, GE; Williams, M | 1 |
Hirose, T; Kikuchi, T; Miwa, T; Morita, S; Oshiro, Y; Tottori, K; Uwahodo, Y | 1 |
6 other study(ies) available for spiperone and 4-butyrolactone
Article | Year |
---|---|
Pituitary and brain D2 receptor density measured in vitro and in vivo in EEDQ treated male rats.
Topics: 4-Butyrolactone; Animals; Brain; Cell Membrane; Corpus Striatum; Kinetics; Limbic System; Male; Pituitary Gland; Quinolines; Raclopride; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Salicylamides; Spiperone; Tritium | 1991 |
Further in vitro and in vivo studies with the putative presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin.
Topics: 4-Butyrolactone; Animals; Apomorphine; Binding, Competitive; Corpus Striatum; Dopamine; In Vitro Techniques; Male; Motor Activity; Naphthalenes; Piperazines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Neurotransmitter; Spiperone; Substantia Nigra; Synaptosomes; Tetrahydronaphthalenes | 1987 |
Dopamine receptor stimulating effects of chanoclavine analogues, tricyclic ergot alkaloids, in the brain.
Topics: 4-Butyrolactone; Animals; Binding, Competitive; Brain; Catechols; Corpus Striatum; Dihydroxyphenylalanine; Ergolines; Ergot Alkaloids; In Vitro Techniques; Male; Mice; Rats; Rats, Inbred Strains; Receptors, Dopamine; Rotation; Spiperone; Stereotyped Behavior; Time Factors | 1987 |
Evidence for an irreversible interaction of bromocryptine with central dopamine receptors.
Topics: 4-Butyrolactone; Animals; Brain; Bromocriptine; Corpus Striatum; Dopa Decarboxylase; Electrophysiology; Kinetics; Male; Olfactory Bulb; Rats; Receptors, Dopamine; Spiperone; Tyrosine 3-Monooxygenase | 1980 |
A pharmacological comparison of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99) and N-n-propyl-3-(3-hydroxyphenyl)piperidine with (3-PPP) selected dopamine agonists.
Topics: 4-Butyrolactone; Animals; Apomorphine; Cell Membrane; Corpus Striatum; Female; Humans; Hydroxydopamines; Naphthalenes; Oxidopamine; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Tetrahydronaphthalenes | 1982 |
7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.
Topics: 4-Butyrolactone; Animals; Antipsychotic Agents; Apomorphine; Aripiprazole; Catalepsy; Corpus Striatum; Dihydroxyphenylalanine; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Male; Mice; Mice, Inbred ICR; Motor Activity; Oxidopamine; Piperazines; Presynaptic Terminals; Quinolones; Radioligand Assay; Rats; Reserpine; Spiperone; Stereotyped Behavior; Synapses; Tritium | 1995 |